In the BioHarmony Drug Report Database

"Preview" Icon

Fospropofol

Lusedra (fospropofol) is a small molecule pharmaceutical. Fospropofol was first approved as Lusedra on 2008-12-12. Lusedra’s patent is valid until 2022-07-01 (FDA).

 

Trade Name

 

Lusedra
 

Common Name

 

fospropofol
 

ChEMBL ID

 

CHEMBL1201766
 

Indication

 

 

Drug Class

 

Phosphoro-derivatives

Image (chem structure or protein)

Fospropofol structure rendering